China Medical (CHSYF) 1.6500 $CHSYF Week In Review: WuXi

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Medical (CHSYF) 1.6500 $CHSYF

Week In Review: WuXi PharmaTech Pays $65 Million For Genomics Company
ChinaBio Today - Seeking Alpha - Sun Jan 11, 10:10AM CST
Deals and Financings WuXi PharmaTech (NYSE: WX ), the China-US CRO/CMO, paid $65 million in cash to acquire NextCODE Health, a genomic analysis and bioinformatics company with operations in the US and Iceland (see story ). One year ago, NextCODE...
AKRX: 43.10 (+0.68), TEVA: 61.38 (-0.75), WX: 40.50 (+0.96), NVS: 103.22 (+3.20), MS: 38.64 (+0.54)

Hepatocellular Carcinoma - Pipeline Review, H2 2014
M2 - Mon Dec 01, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/8fjnjx/hepatocellular) has announced the addition of the "Hepatocellular Carcinoma - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Hepatocellular Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatocellular Carcinoma and special features on late-stage and discontinued projects. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Hepatocellular Carcinoma - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Hepatocellular Carcinoma pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - 4SC - AbbVie - Acceleron Pharma - ACROVIS biostructures - Alfact Innovation - Alnylam - Amgen - AndroScienceration - ArQule - Arrowhead Researchration - Astex - AstraZeneca - Avidin Ltd - Bayer - Bio-Cancer Treatment - Blueprint Medicines - Boehringer Ingelheim - Boston Biomedical - Can-Fite BioPharma - CASI - CCRP Therapeutics - Celgeneration - Celsionration - China Medical System Holdings - Chroma Therapeutics - CrystalGenomics - CytRxration - Delcath Systems - Dicerna - Digna Biotech S.L. - Eisai. - Eli Lilly and Company - Endocyte - Exelixis - F. Hoffmann-La Roche - Gamida Cell - Geneluxration - Genoscience Pharma - GenSpera - GlaxoSmithKline - Green Cross Cellration - Immune Network - Immunicum AB - Immunomedics - Immunovative Therapies - Immuron - In Cell Art - Incuron LLC - Intezyne Inc - KAEL-GemVax. - KAHR medical - Kowa Company - La Jolla Pharmaceutical Company - Ligand - Lixte Biotechnology Holdings - MaxCyte - Merck KGaA - Millennium - MolMed S.p.A. - MultiCell Technologies - NeoStem - Nerviano Medical Sciences - Novartis - Nymox Pharmaceuticalration - Omerosration - Oncolys BioPharma - OncoTherapy Science - Ono Pharmaceutical. - Onxeo SA - Otsuka Holdings. - Panacea - Peregrine - Pfizer - PharmaEssentiaration - PhaseRx - Polaris - Priaxon - Progen - Provecs Medical - Provectus Biopharmaceuticals - Quantum - Raptor - Regulus Therapeutics - Rigontec - Santaris Pharma A/S - Sevion Therapeutics - Shanghai Sunway Biotech - Shenogen Pharma - Silence Therapeutics - SillaJen Co. - Simcere Pharmaceutical - Solasia Pharma K.K. - Synta - Taiwan Liposome Company - Tekmira - Therametrics holding - Therapure Biopharma - THERAVECTYS SA - Threshold - Toko Pharmaceutical Industries. - TRACON - Vaxon Biotech - Vertexrporated - Vicus Therapeutics LLC - Virttu Biologics For more information visit http://www.researchandmarkets.com/research/8f...tocellular
IMMU: 4.20 (+0.24), AMGN: 154.10 (+2.79), RGLS: 10.14 (+0.30), LLY: 88.29 (+0.81), GSK: 42.45 (+0.65), PVCT: 0.51 (+0.01), CANF: 2.00 (+0.09), DCTH: 0.84 (unch), NVS: 103.22 (+3.20), XLRN: 30.03 (+0.20)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zika Virus: A Surprising Ally in Brain Cancer Fight

Updated Category News Views 6

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 5

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Updated Category News Views 3

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 9

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 12

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 10

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 6

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 13

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 7

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Art Print Paper: Finding the Perfect Match for Masterpieces

Updated Category News Views 13

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding China’s Continuous Fight Against Corruption

Updated Category News Views 130

China's Unwavering Commitment to Anti-Corruption The ongoing anti-corruption campaign in China has captured global attention, revealing a unique approach that contrasts sharply with Western models. Chinese leadership emphasizes the importance of strict governance to build trust and maintain integrity within the Party. Leadership and Governance The Political Bureau of the...

Continue Reading
Celularity Takes Steps to Address Nasdaq Filing Compliance Issues

Updated Category News Views 168

Celularity's Nasdaq Notification and Response Celularity Inc. (Nasdaq: CELU), a leader in regenerative and cellular medicine, recently received important communication from Nasdaq regarding its filing obligations. The company was informed that it did not file its Quarterly Report on Form 10-Q on time for the period ending June 30, 2025. This communication has significant...

Continue Reading
Scott Armul Takes the Helm as Executive VP at Vertiv Holdings

Updated Category News Views 126

Scott Armul Promoted to Executive Vice President Vertiv Holdings Co (NYSE: VRT), a leader in critical digital infrastructure and continuity solutions, has made a significant move by promoting Scott Armul to the position of executive vice president for global portfolio and business units. This decision is effective from January 1, 2025, marking a pivotal point in the...

Continue Reading
California's New Climate Superfund: A Game Changer for Residents

Updated Category News Views 255

California's Innovative Climate Superfund Initiative In an ambitious effort to enhance its budget while tackling climate change, California has proposed a groundbreaking plan—AB 1243 and SB 684, known as the Polluters Pay Climate Superfund Act. Aimed at holding the world's largest fossil fuel companies accountable, this legislation seeks to alleviate financial burdens...

Continue Reading
New Fortress Energy Inc. Faces Class Action Amid Share Drop

Updated Category News Views 46

New Fortress Energy Inc. Faces Class Action Amid Share Drop Investors in New Fortress Energy Inc. should be aware of a significant legal development. A class action lawsuit has been initiated in the U.S. District Court for the Southern District, aimed at protecting the rights of shareholders who purchased company securities during a specified time frame. This lawsuit has...

Continue Reading